Business · 03/02/2006Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for SURPASS Patent Extension Application
Summary
The Food and Drug Administration (FDA) has determined the regulatory review period for SURPASS, a patent extension application for an animal drug product, and is publishing this notice as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →